Health Dictionary Find a Doctor

Chorioamnionitis


For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]

Synonyms and keywords: Intra-amniotic infection; IAI

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]

Overview

Chorioamnionitis is an inflammatory condition of pregnancy affecting the uterus. It is a bacterial infection of the amniotic sac and the surrounding amniotic fluid. Chorioamnionitis is extremely dangerous to both the mother and fetus and is the most common cause of premature labor. Chorioamnionitis may be classified into several subtypes based on the presentation of the patient, the type of infiltrating cells, anatomical regions infiltrated by neutrophils (stage), and the intensity of inflammation (grade). Chorioamnionitis is an inflammatory condition of fetal membranes which is usually caused by infectious etiology. The opaque appearance of fetal membranes is a characteristic gross pathologic finding of chorioamnionitis. neutrophilic infiltration of the amniotic cavity and/or chorionic plate is the characteristic microscopic finding of chorioamnionitis. Chorioamnionitis may be caused by either bacterial, fungal, or viral microorganisms. Chorioamnionitis must be differentiated from other conditions that cause maternal fever, abdominal pain, or maternal/fetal tachycardia such as epidural-related fever, extrauterine infections, and noninfectious conditions characterized by abdominal pain. Epidural-related fever should be considered in patients with epidural anesthesia who have low grade fever without maternal/fetal tachycardia during the intrapartum period. Extrauterine infections should be considered in patients with fever and abdominal pain. And lastly, noninfectious conditions such as placental abruption should be considered in patients with abdominal pain in the absence of fever. The prevalence of chorioamnionitis was estimated to be approximately 4,000 cases per 100,000 individuals worldwide. Chorioamnionitis more commonly affects individuals < 18 years of age. Gestational age is also a strong predictor of chorioamnionitis with increased prevalence in people who delivered between 21 and 24 weeks of gestation. Male infants are more commonly affected than females. Chorioamnionitis usually affects individuals of Hispanics and Asian/Pacific Islanders. Common risk factors in the development of chorioamnionitis include preterm premature rupture of membranes (PPROM), prematurity, nulliparity, prolonged labor and rupture of membranes, multiple digital vaginal examinations, meconium stained amniotic fluid, internal fetal monitoring, epidural anesthesia, immunocompromised state, maternal behavioral conditions, and infections. Clinical findings associated with chorioamnionitis include maternal fever, uterine tenderness, purulent/foul-smelling amniotic fluid, maternal/fetal tachycardia. Common fetal complications of chorioamnionitis include preterm birth, neonatal sepsis, neurologic complications, respiratory complications. Common maternal complications of chorioamnionitis include maternal sepsis, infections, and labor-related complications (e.g., cesarean section, postpartum hemorrhage, etc.). There is no single diagnostic study of choice for the diagnosis of chorioamnionitis, but chorioamnionitis can be diagnosed based on the clinical presentation, laboratory findings, and/or histopathologic evaluation. The diagnosis of clinical chorioamnionitis is solely based on clinical features include maternal fever, uterine tenderness, maternal/fetal tachycardia, and foul-smelling/purulent amniotic fluid. And the gold standard (test) for the diagnosis of chorioamnionitis is a microbiological culture of the amniotic fluid. Common physical examination findings of chorioamnionitis include fever, abdominal pain, uterine tenderness, tachycardia, and foul-smelling vaginal discharge. Laboratory findings consistent with the diagnosis of chorioamnionitis include maternal leukocytosis, left shift or elevated band count, amniotic fluid findings (e.g., positive amniotic fluid microbiological culture results, bacteria or white blood cells on gram stain, decreased glucose level, elevated IL-6 level, etc.), and histologic findings such as neutrophilic infiltration of chorioamniotic membranes. There are no ECG findings associated with chorioamnionitis. There are no x-ray findings associated with chorioamnionitis. There are no ultrasound findings associated with chorioamnionitis. However, an ultrasound may be helpful in the diagnosis of complications of chorioamnionitis, which include postpartum hemorrhage, pelvic abscesses, endomyometritis, intraventricular hemorrhage, periventricular leukomalacia, respiratory distress syndrome, and bronchopulmonary dysplasia. There are no CT scan findings associated with chorioamnionitis. However, a CT scan may be helpful in the diagnosis of complications of chorioamnionitis, which include pelvic infections and abscesses, adrenal abscesses, and subphrenic abscess. There are no MRI findings associated with chorioamnionitis. However, an MRI may be helpful in the diagnosis of complications of chorioamnionitis, which include spontaneous preterm delivery, white matter injury (WMI), and intraventricular hemorrhage (IVH). Magnetic resonance spectroscopy(MRS) may be helpful for the detection of neuroinflammation during histologic chorioamnionitis. Furthermore, it may suggest a poor neurodevelopmental outcome (e.g. motor development, cognitive development, etc.) in these infants. There are no other diagnostic studies associated with chorioamnionitis. Antimicrobial therapy is indicated among patients with chorioamnionitis. The preferred regimen is a combination of ampicillin and gentamicin. Supportive therapy, such as antipyretics, may also be used. Surgical intervention is not recommended for the management of chorioamnionitis. Effective measures for the primary prevention of chorioamnionitis include induction of labor after 34 weeks of gestation and administration of prophylactic antimicrobial therapy in the presence of preterm premature rupture of membranes (PPROM). There are no established measures for the secondary prevention of chorioamnionitis.

Classification

Chorioamnionitis may be classified into several subtypes based on the presentation of the patient, the type of infiltrating cells, anatomical regions infiltrated by neutrophils (stage), and the intensity of inflammation (grade).

Pathophysiology

Chorioamnionitis is an inflammatory condition of fetal membranes which is usually caused by infectious etiology. The opaque appearance of fetal membranes is a characteristic gross pathologic finding of chorioamnionitis. neutrophilic infiltration of the amniotic cavity and/or chorionic plate is the characteristic microscopic finding of chorioamnionitis.

Causes

Chorioamnionitis may be caused by either bacterial, fungal, or viral microorganisms.

Differentiating Chorioamnionitis from Other Diseases

Chorioamnionitis must be differentiated from other conditions that cause maternal fever, abdominal pain, or maternal/fetal tachycardia such as epidural-related fever, extrauterine infections, and noninfectious conditions characterized by abdominal pain. Epidural-related fever should be considered in patients with epidural anesthesia who have low grade fever without maternal/fetal tachycardia during the intrapartum period. Extrauterine infections should be considered in patients with fever and abdominal pain. And lastly, noninfectious conditions such as placental abruption should be considered in patients with abdominal pain in the absence of fever.

Epidemiology and Demographics

The prevalence of chorioamnionitis was estimated to be approximately 4,000 cases per 100,000 individuals worldwide. Chorioamnionitis more commonly affects individuals < 18 years of age. Gestational age is also a strong predictor of chorioamnionitis with increased prevalence in people who delivered between 21 and 24 weeks of gestation. Male infants are more commonly affected than females. Chorioamnionitis usually affects individuals of Hispanics and Asian/Pacific Islanders.

Risk Factors

Common risk factors in the development of chorioamnionitis include preterm premature rupture of membranes (PPROM), prematurity, nulliparity, prolonged labor and rupture of membranes, multiple digital vaginal examinations, meconium stained amniotic fluid, internal fetal monitoring, epidural anesthesia, immunocompromised state, maternal behavioral conditions, and infections.

Natural History, Complications, and Prognosis

Clinical findings associated with chorioamnionitis include maternal fever, uterine tenderness, purulent/foul-smelling amniotic fluid, maternal/fetal tachycardia. Common fetal complications of chorioamnionitis include preterm birth, neonatal sepsis, neurologic complications, respiratory complications. Common maternal complications of chorioamnionitis include maternal sepsis, infections, and labor-related complications (e.g., cesarean section, postpartum hemorrhage, etc.)

Diagnosis

Diagnostic Study of Choice

There is no single diagnostic study of choice for the diagnosis of chorioamnionitis, but chorioamnionitis can be diagnosed based on the clinical presentation, laboratory findings, and/or histopathologic evaluation. The diagnosis of clinical chorioamnionitis is solely based on clinical features include maternal fever, uterine tenderness, maternal/fetal tachycardia, and foul-smelling/purulent amniotic fluid. And the gold standard (test) for the diagnosis of chorioamnionitis is a microbiological culture of the amniotic fluid.

History and Symptoms

The hallmark of chorioamnionitis is maternal fever. The presence of uterine tenderness, purulent/foul-smelling amniotic fluid, and maternal/fetal tachycardia is suggestive of chorioamnionitis.

Physical Examination

Common physical examination findings of chorioamnionitis include fever, abdominal pain, uterine tenderness, tachycardia, and foul-smelling vaginal discharge.

Laboratory Findings

Laboratory findings consistent with the diagnosis of chorioamnionitis include maternal leukocytosis, left shift or elevated band count, amniotic fluid findings (e.g., positive amniotic fluid microbiological culture results, bacteria or white blood cells on gram stain, decreased glucose level, elevated IL-6 level, etc.), and histologic findings such as neutrophilic infiltration of chorioamniotic membranes.

Electrocardiogram

There are no ECG findings associated with chorioamnionitis.

X-ray

There are no x-ray findings associated with chorioamnionitis.

Echocardiography and Ultrasound

There are no ultrasound findings associated with chorioamnionitis. However, an ultrasound may be helpful in the diagnosis of complications of chorioamnionitis, which include postpartum hemorrhage, pelvic abscesses, endomyometritis, intraventricular hemorrhage, periventricular leukomalacia, respiratory distress syndrome, and bronchopulmonary dysplasia.

CT scan

There are no CT scan findings associated with chorioamnionitis. However, a CT scan may be helpful in the diagnosis of complications of chorioamnionitis, which include pelvic infections and abscesses, adrenal abscesses, and subphrenic abscess.

MRI

There are no MRI findings associated with chorioamnionitis. However, an MRI may be helpful in the diagnosis of complications of chorioamnionitis, which include spontaneous preterm delivery, white matter injury (WMI), and intraventricular hemorrhage (IVH).

Other Imaging Findings

Magnetic resonance spectroscopy(MRS) may be helpful for the detection of neuroinflammation during histologic chorioamnionitis. Furthermore, it may suggest a poor neurodevelopmental outcome (e.g. motor development, cognitive development, etc.) in these infants.

Other Diagnostic Studies

There are no other diagnostic studies associated with chorioamnionitis.

Treatment

Medical Therapy

Antimicrobial therapy is indicated among patients with chorioamnionitis. The preferred regimen is a combination of ampicillin and gentamicin. Supportive therapy, such as antipyretics, may also be used.

Surgery

Surgical intervention is not recommended for the management of chorioamnionitis.

Primary Prevention

Effective measures for the primary prevention of chorioamnionitis include induction of labor after 34 weeks of gestation and administration of prophylactic antimicrobial therapy in the presence of preterm premature rupture of membranes (PPROM).

Secondary Prevention

There are no established measures for the secondary prevention of chorioamnionitis.

References

Template:WH Template:WS

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]

Overview

There is limited information about the historical perspective of chorioamnionitis.

Historical Perspective

There is limited information about the historical perspective of chorioamnionitis.

References

Template:WH Template:WS

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]

Overview

Chorioamnionitis may be classified into several subtypes based on the presentation of the patient, the type of infiltrating cells, anatomical regions infiltrated by neutrophils (stage), and the intensity of inflammation (grade).

Classification

Chorioamnionitis may be classified into several subtypes based on the presentation of the patient, the type of infiltrating cells, anatomical regions infiltrated by neutrophils (stage), and the intensity of inflammation (grade).[1]

  • Chorioamnionitis may be classified according to the absence or presence of clinical signs and laboratory findings into two groups: clinical chorioamnionitis, and subclinical/histologic chorioamnionitis.[2][3]
  • Chorioamnionitis may be classified into acute and chronic forms, depending on the type of infiltrating cells.[4]
    • Acute and chronic chorioamnionitis indicate the infiltration of the fetal membranes by PMNs and monocytes, respectively.
  • The staging of chorioamnionitis is based on the anatomical regions infiltrated by neutrophils.[1]
    • Stage 1 represents the infiltration of chorion or subchorionic space by neutrophils.
    • Stage 2 represents the infiltration of chorionic connective tissue and/or amnion or the chorionic plate by neutrophils.
    • Stage 3 represents the necrotizing chorioamnionitis, indicates the edema and necrosis of the amniotic epithelium.
  • The grading of chorioamnionitis is based on the intensity of inflammation.[1]
    • Grade 1, mild to moderate inflammation, represent the infiltration of fetal membranes by small clusters of maternal neutrophils.
    • Grade 2, severe inflammation, represents the presence of at least 3 chorionic microabscesses (cluster of neutrophils measuring ≥ 10 x 20 cells) or the presence of neutrophils of ≥ 10 cells in width that involve at least half of the subchorionic fibrin or one cycle around the membrane roll.
  • The staging system might be more effective to establish the severity of inflammation than the grading system.[1]

References

  1. 1.0 1.1 1.2 1.3 Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM (October 2015). “Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance”. Am J Obstet Gynecol. 213 (4 Suppl): S29–52. doi:10.1016/j.ajog.2015.08.040. PMC 4774647. PMID 26428501.
  2. Peng CC, Chang JH, Lin HY, Cheng PJ, Su BH (June 2018). “Intrauterine inflammation, infection, or both (Triple I): A new concept for chorioamnionitis”. Pediatr Neonatol. 59 (3): 231–237. doi:10.1016/j.pedneo.2017.09.001. PMID 29066072.
  3. Ericson JE, Laughon MM (March 2015). “Chorioamnionitis: implications for the neonate”. Clin Perinatol. 42 (1): 155–65, ix. doi:10.1016/j.clp.2014.10.011. PMC 4331454. PMID 25678002.
  4. Chi BH, Mudenda V, Levy J, Sinkala M, Goldenberg RL, Stringer JS (January 2006). “Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus-1 transmission”. Am J Obstet Gynecol. 194 (1): 174–81. doi:10.1016/j.ajog.2005.06.081. PMID 16389028.

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]

Overview

Chorioamnionitis is an inflammatory condition of fetal membranes which is usually caused by infectious etiology. The opaque appearance of fetal membranes is a characteristic gross pathologic finding of chorioamnionitis. neutrophilic infiltration of the amniotic cavity and/or chorionic plate is the characteristic microscopic finding of chorioamnionitis.

Pathophysiology

Pathogenesis

Chorioamnionitis is an inflammatory condition of fetal membranes which is usually caused by infectious etiology. The pathogenesis can be further divided into 4 categories based on the anatomical route of the introduction of the microorganism:[1]

  • Ascending infection might originate from the maternal genital tract (the most common route).
    • Vaginal and enteric flora are usually transmitted via the ascending route to the fetal membranes.
  • Iatrogenic infection might be caused by invasive procedures (e.g., amniocentesis).
  • Maternal infections such as listeria monocytogenes, might infect fetal membranes through the placenta by the hematogenous route.
  • In mothers with hepatic or renal diseases, the infection of fetal membranes might be originated by peritoneal infections via the route of fallopian tubes.

Genetics

Genes involved in the pathogenesis of chorioamnionitis include:[2][3]

  • Placental IL-6 (minor C allele at the IL6 SNP)
  • IL10
  • MBL2
  • TNFRSF6
  • TGFB1

Gross Pathology

On gross pathology, the opaque appearance of fetal membranes is a characteristic finding of chorioamnionitis.[4]

  • The presence of opaque fetal membranes might indicate an increased risk of complications of chorioamnionitis in newborns.

Microscopic Pathology

On microscopic histopathological analysis, neutrophilic infiltration of the amniotic cavity and/or neutrophilic infiltration of the chorionic plate are characteristic findings of chorioamnionitis.[5]

  • Decidua of the placenta is originated from the mother which might include the neutrophils of mother.
  • Chorioamnionic membranes are originated from the fetus which do not include neutrophils in physiologic settings. However, in case of chorioamnionitis, maternal neutrophils migrate into these membranes in the presence of chemotaxis.

References

  1. Ericson JE, Laughon MM (March 2015). “Chorioamnionitis: implications for the neonate”. Clin Perinatol. 42 (1): 155–65, ix. doi:10.1016/j.clp.2014.10.011. PMC 4331454. PMID 25678002.
  2. Konwar C, Del Gobbo GF, Terry J, Robinson WP (February 2019). “Association of a placental Interleukin-6 genetic variant (rs1800796) with DNA methylation, gene expression and risk of acute chorioamnionitis”. BMC Med Genet. 20 (1): 36. doi:10.1186/s12881-019-0768-0. PMC 6387541. PMID 30795743.
  3. Annells MF, Hart PH, Mullighan CG, Heatley SL, Robinson JS, McDonald HM (February 2005). “Polymorphisms in immunoregulatory genes and the risk of histologic chorioamnionitis in Caucasoid women: a case control study”. BMC Pregnancy Childbirth. 5 (1): 4. doi:10.1186/1471-2393-5-4. PMC 554771. PMID 15723707.
  4. Horikoshi Y, Yaguchi C, Furuta-Isomura N, Itoh T, Kawai K, Oda T, Matsumoto M, Kohmura-Kobayashi Y, Tamura N, Uchida T, Kanayama N, Itoh H (2020). “Gross appearance of the fetal membrane on the placental surface is associated with histological chorioamnionitis and neonatal respiratory disorders”. PLoS One. 15 (11): e0242579. doi:10.1371/journal.pone.0242579. PMC 7704006 Check |pmc= value (help). PMID 33253176 Check |pmid= value (help).
  5. Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM (October 2015). “Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance”. Am J Obstet Gynecol. 213 (4 Suppl): S29–52. doi:10.1016/j.ajog.2015.08.040. PMC 4774647. PMID 26428501.

Template:WH Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2] ; Luke Rusowicz-Orazem, B.S.

Overview

Causes

Chorioamnionitis may be caused by either bacterial, fungal, or viral microorganisms.[1]

Common Causes

Common bacterial causes of chorioamnionitis include:[1][2]

Common causative pathogens could be further divided based on the clinical outcome


Causes by Organ System

Cardiovascular No underlying causes
Chemical/Poisoning No underlying causes
Dental No underlying causes
Dermatologic No underlying causes
Drug Side Effect No underlying causes
Ear Nose Throat No underlying causes
Endocrine No underlying causes
Environmental No underlying causes
Gastroenterologic Escherichia coli
Genetic No underlying causes
Hematologic Mycoplasma hominis
Iatrogenic No underlying causes
Infectious Disease Adenovirus, Bacteroides  , Candida albicans, Chlamydia trachomatis, Endometritis, Enterobacteriaceae, Escherichia coli, Fusobacteria sp., Gardnerella vaginalis  , Gram-negative anaerobes , Listeria monocytogenes, Mycoplasma hominis  , Prevotella bivius, Streptococcus group b, Streptococcus group a, Ureaplasma urealyticum
Musculoskeletal/Orthopedic No underlying causes
Neurologic Mycoplasma hominis
Nutritional/Metabolic No underlying causes
Obstetric/Gynecologic Chlamydia trachomatis, Endometritis, Prolonged labor
Oncologic No underlying causes
Ophthalmologic No underlying causes
Overdose/Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal/Electrolyte No underlying causes
Rheumatology/Immunology/Allergy No underlying causes
Sexual Gardnerella vaginalis
Trauma No underlying causes
Urologic Urinary tract infection
Miscellaneous No underlying causes

Common Causes in Alphabetical Order

References

  1. 1.0 1.1 1.2 Fowler JR, Simon LV. PMID 30335284. Missing or empty |title= (help)
  2. 2.0 2.1 Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM (October 2015). “Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance”. Am J Obstet Gynecol. 213 (4 Suppl): S29–52. doi:10.1016/j.ajog.2015.08.040. PMC 4774647. PMID 26428501.

Template:WH Template:WS

Differentiating Chorioamnionitis from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]

Overview

Chorioamnionitis must be differentiated from other conditions that cause maternal fever, abdominal pain, or maternal/fetal tachycardia such as epidural-related fever, extrauterine infections, and noninfectious conditions characterized by abdominal pain. Epidural-related fever should be considered in patients with epidural anesthesia who have low grade fever without maternal/fetal tachycardia during the intrapartum period. Extrauterine infections should be considered in patients with fever and abdominal pain. And lastly, noninfectious conditions such as placental abruption should be considered in patients with abdominal pain in the absence of fever.

Differentiating Chorioamnionitis From Other Diseases

Chorioamnionitis must be differentiated from other conditions that cause maternal fever, abdominal pain, or maternal/fetal tachycardia such as epidural-related fever, extrauterine infections, and noninfectious conditions characterized by abdominal pain.[1]

  • Epidural-related fever should be considered in patients with epidural anesthesia who have low grade fever without maternal/fetal tachycardia during the intrapartum period.
  • Extrauterine infections should be considered in patients with fever and abdominal pain. Extrauterine infections that must be differentiated from chorioamnionitis include:
  • Noninfectious conditions should be considered in patients with abdominal pain in the absence of fever. Noninfectious conditions that must be differentiated from chorioamnionitis include:


Chorioamnionitis, must be differentiated from other diseases that may cause, fever, abdominal pain, and maternal/fetal tachycardia. The table below, summarizes the differential diagnosis for chorioamnionitis:

Disease Findings
Epidural-Related Fever Intrapartum fever (≥38 °C), Absence of other clinical findings of intrauterine inflammation (abdominal pain, maternal/fetal tachycardia, etc.)[2][1]
Appendicitis Presents with abdominal pain that begins around the umbilicus, then migrates to the right lower quadrant (relatively rare but also possible at right upper quadrant), nausea vomiting, abdominal guarding, deep tenderness at MBburney’s point, dysuria[3]
Pneumonia Presents with fever, productive cough, pleuritic chest pain, dyspnea, rigor, perspiration, and findings on auscultation such as inspiratory rales localized to the affected area
Influenza Presents with acute fever, headache, cough, rigor, perspiration, myalgias, and malaise[4]
Pyelonephritis Presents with fever, chills, malaise, dysuria, urinary urgency, polyuria, nausea, flank pain[5]
Others Thrombophlebitis, placental abruption, colitis, connective tissue disorders, and round ligament pain can produce abdominal pain that may be confused with chorioamnionitis. However, the absence of fever indicates these conditions rather than chorioamnionitis.[1]

References

  1. 1.0 1.1 1.2 Tita AT, Andrews WW (June 2010). “Diagnosis and management of clinical chorioamnionitis”. Clin Perinatol. 37 (2): 339–54. doi:10.1016/j.clp.2010.02.003. PMC 3008318. PMID 20569811.
  2. Jansen S, Lopriore E, Naaktgeboren C, Sueters M, Limpens J, van Leeuwen E, Bekker V (2020). “Epidural-Related Fever and Maternal and Neonatal Morbidity: A Systematic Review and Meta-Analysis”. Neonatology. 117 (3): 259–270. doi:10.1159/000504805. PMID 31991422.
  3. Franca Neto AH, Amorim MM, Nóbrega BM (2015). “Acute appendicitis in pregnancy: literature review”. Rev Assoc Med Bras (1992). 61 (2): 170–7. doi:10.1590/1806-9282.61.02.170. PMID 26107368.
  4. Gaitonde DY, Moore FC, Morgan MK (December 2019). “Influenza: Diagnosis and Treatment”. Am Fam Physician. 100 (12): 751–758. PMID 31845781.
  5. Johnson JR, Russo TA (January 2018). “Acute Pyelonephritis in Adults”. N Engl J Med. 378 (1): 48–59. doi:10.1056/nejmcp1702758. PMID 29298155.

Template:WH Template:WS

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]

Overview

The prevalence of chorioamnionitis was estimated to be approximately 4,000 cases per 100,000 individuals worldwide. Chorioamnionitis more commonly affects individuals < 18 years of age. Gestational age is also a strong predictor of chorioamnionitis with increased prevalence in people who delivered between 21 and 24 weeks of gestation. Male infants are more commonly affected than females. Chorioamnionitis usually affects individuals of Hispanics and Asian/Pacific Islanders.

Epidemiology and Demographics

Prevelance

  • Worldwide, the prevalence of chorioamnionitis is approximately 4,000 per 100,000 persons.[1]
    • In developed countries, the prevalence of chorioamnionitis is 970 per 100,000 persons.[2]

Age

  • Chorioamnionitis is more commonly seen in patients < 18 years of age.[2]

Gestational Age

  • The prevalence of chorioamnionitis decreases with gestational age until 37-40 weeks of gestation, then slightly increases again.
    • Chorioamnionitis most commonly affects patients who delivered between 21 and 24 weeks of gestation.
      • It is worth mentioning that the frequency of chorioamnionitis is approximately 94% in this group. [3]

Gender

  • Male infants are more commonly affected with chorioamnionitis than female infants.[2]

Race

  • Chorioamnionitis usually affects individuals of non-White races. White individuals are less likely to develop chorioamnionitis.[2]
    • Chorioamnionitis is more prevalent in Hispanics and Asian/Pacific Islanders.
    • Although individuals of the Black race usually less affected than Hispanics and Asian/Pacific Islanders, the prevalence of chorioamnionitis is higher in individuals of the black race than whites.

References

  1. Fowler JR, Simon LV. PMID 30335284. Missing or empty |title= (help)
  2. 2.0 2.1 2.2 2.3 Malloy MH (August 2014). “Chorioamnionitis: epidemiology of newborn management and outcome United States 2008”. J Perinatol. 34 (8): 611–5. doi:10.1038/jp.2014.81. PMID 24786381.
  3. Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM (October 2015). “Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance”. Am J Obstet Gynecol. 213 (4 Suppl): S29–52. doi:10.1016/j.ajog.2015.08.040. PMC 4774647. PMID 26428501.

Template:WH Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2] ; Abdurahman Khalil, M.D. [3]

Overview

Common risk factors in the development of chorioamnionitis include preterm premature rupture of membranes (PPROM), prematurity, nulliparity, prolonged labor and rupture of membranes, multiple digital vaginal examinations, meconium stained amniotic fluid, internal fetal monitoring, epidural anesthesia, immunocompromised state, maternal behavioral conditions, and infections.

Risk Factors

Common risk factors in the development of chorioamnionitis include:[1][2]

References

  1. Tita AT, Andrews WW (June 2010). “Diagnosis and management of clinical chorioamnionitis”. Clin Perinatol. 37 (2): 339–54. doi:10.1016/j.clp.2010.02.003. PMC 3008318. PMID 20569811.
  2. Alexander JM, McIntire DM, Leveno KJ (August 1999). “Chorioamnionitis and the prognosis for term infants”. Obstet Gynecol. 94 (2): 274–8. doi:10.1016/s0029-7844(99)00256-2. PMID 10432142.

Template:WH Template:WS

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].

Screening

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:

  • [Condition 1]
  • [Condition 2]
  • [Condition 3]

References

Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]

Overview

Clinical findings associated with chorioamnionitis include maternal fever, uterine tenderness, purulent/foul-smelling amniotic fluid, maternal/fetal tachycardia. Common fetal complications of chorioamnionitis include preterm birth, neonatal sepsis, neurologic complications, respiratory complications. Common maternal complications of chorioamnionitis include maternal sepsis, infections, and labor-related complications (e.g., cesarean section, postpartum hemorrhage, etc.)

Natural History, Complications, and Prognosis

Natural History

The symptoms of chorioamnionitis usually develop during the pregnancy, and start with symptoms such as maternal fever, uterine tenderness, purulent/foul-smelling amniotic fluid, maternal/fetal tachycardia.[1]

Complications

Fetal complications that can develop as a result of chorioamnionitis are:[2][3]

Maternal complications that can develop as a result of chorioamnionitis are:[3][1]

Prognosis

The presence of cesarean delivery for dystocia, prolonged labor times (≥ 10 h), or administration of oxytocin during labor are associated with a particularly poor prognosis among infants exposed to chorioamnionitis.[4]

References

  1. 1.0 1.1 Tita AT, Andrews WW (June 2010). “Diagnosis and management of clinical chorioamnionitis”. Clin Perinatol. 37 (2): 339–54. doi:10.1016/j.clp.2010.02.003. PMC 3008318. PMID 20569811.
  2. Ericson JE, Laughon MM (March 2015). “Chorioamnionitis: implications for the neonate”. Clin Perinatol. 42 (1): 155–65, ix. doi:10.1016/j.clp.2014.10.011. PMC 4331454. PMID 25678002.
  3. 3.0 3.1 Fowler JR, Simon LV. PMID 30335284. Missing or empty |title= (help)
  4. Alexander JM, McIntire DM, Leveno KJ (August 1999). “Chorioamnionitis and the prognosis for term infants”. Obstet Gynecol. 94 (2): 274–8. doi:10.1016/s0029-7844(99)00256-2. PMID 10432142.

Template:WH Template:WS

Diagnosis

Diagnosis

Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-ray FindingsEchocardiography and Ultrasound | CT Scan FindingsMRI Findings | Other Imaging Findings | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

See also

See also

Cerebral palsy

Template:Certain conditions originating in the perinatal period


Template:WS

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH